Zhao D, Zarif M, Eladl E, Capo-Chichi JM, et al. NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1. Leuk Res 2022;118:106869.
PMID: 35636054